Founded in 1941 in Tokyo as an optical glass production plant, Hoya is one of the largest eyeglass lens manufacturers in the world. Leveraging its technology know-how in glass manufacturing, Hoya entered the mask blanks business in 1974. Now although its life care business accounts for 67% of its total revenue, almost half of its profit before tax comes from its higher-margin IT business.
1944
37.4K+
LTM Revenue $5.8B
LTM EBITDA $2.0B
$31.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Hoya has a last 12-month revenue of $5.8B and a last 12-month EBITDA of $2.0B.
In the most recent fiscal year, Hoya achieved revenue of $5.3B and an EBITDA of $1.9B.
Hoya expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Hoya valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $4.9B | $5.3B | XXX | XXX | XXX |
Gross Profit | $3.8B | $4.2B | XXX | XXX | XXX |
Gross Margin | 77% | 80% | XXX | XXX | XXX |
EBITDA | $1.8B | $1.9B | XXX | XXX | XXX |
EBITDA Margin | 36% | 36% | XXX | XXX | XXX |
Net Profit | $1.1B | $1.1B | XXX | XXX | XXX |
Net Margin | 22% | 21% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Hoya's stock price is JPY 15195 (or $101).
Hoya has current market cap of JPY 5.21T (or $34.6B), and EV of JPY 4.66T (or $31.0B).
See Hoya trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$31.0B | $34.6B | XXX | XXX | XXX | XXX | $3.93 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Hoya has market cap of $34.6B and EV of $31.0B.
Hoya's trades at 5.3x LTM EV/Revenue multiple, and 15.3x LTM EBITDA.
Analysts estimate Hoya's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Hoya and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $31.0B | XXX | XXX | XXX |
EV/Revenue | 5.5x | XXX | XXX | XXX |
EV/EBITDA | 15.6x | XXX | XXX | XXX |
P/E | 26.2x | XXX | XXX | XXX |
P/E/Growth | 2.1x | XXX | XXX | XXX |
EV/FCF | 24.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpHoya's NTM/LTM revenue growth is 7%
Hoya's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $45K for the same period.
Over next 12 months, Hoya's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Hoya's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Hoya and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 8% | XXX | XXX | XXX | XXX |
EBITDA Margin | 35% | XXX | XXX | XXX | XXX |
EBITDA Growth | 7% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 42% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
Opex per Employee | $45K | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 32% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
Polymed | XXX | XXX | XXX | XXX | XXX | XXX |
Schott Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
Fresenius Medical Care | XXX | XXX | XXX | XXX | XXX | XXX |
Fresenius | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Hoya acquired XXX companies to date.
Last acquisition by Hoya was XXXXXXXX, XXXXX XXXXX XXXXXX . Hoya acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Hoya founded? | Hoya was founded in 1944. |
Where is Hoya headquartered? | Hoya is headquartered in Japan. |
How many employees does Hoya have? | As of today, Hoya has 37.4K+ employees. |
Who is the CEO of Hoya? | Hoya's CEO is Mr. Eiichiro Ikeda. |
Is Hoya publicy listed? | Yes, Hoya is a public company listed on TKS. |
What is the stock symbol of Hoya? | Hoya trades under 7741 ticker. |
When did Hoya go public? | Hoya went public in 1961. |
Who are competitors of Hoya? | Similar companies to Hoya include e.g. Ansell, Polymed, Schott Pharma, Fresenius Medical Care. |
What is the current market cap of Hoya? | Hoya's current market cap is $34.6B |
What is the current revenue of Hoya? | Hoya's last 12-month revenue is $5.8B. |
What is the current EBITDA of Hoya? | Hoya's last 12-month EBITDA is $2.0B. |
What is the current EV/Revenue multiple of Hoya? | Current revenue multiple of Hoya is 5.3x. |
What is the current EV/EBITDA multiple of Hoya? | Current EBITDA multiple of Hoya is 15.3x. |
What is the current revenue growth of Hoya? | Hoya revenue growth between 2023 and 2024 was 8%. |
Is Hoya profitable? | Yes, Hoya is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.